BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 Suvilesh KN, Manjunath Y, Pantel K, Kaifi JT. Preclinical models to study patient-derived circulating tumor cells and metastasis. Trends Cancer 2023;9:355-71. [PMID: 36759267 DOI: 10.1016/j.trecan.2023.01.004] [Reference Citation Analysis]
2 Wu X, Zhu H, Xu Y, Kong B, Tan Q. Chronic wounds: pathological characteristics and their stem cell-based therapies. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.11.004] [Reference Citation Analysis]
3 Ruano APC, Gadelha Guimarães AP, Braun AC, Flores BCTCP, Tariki MS, Abdallah EA, Torres JA, Nunes DN, Tirapelli B, de Lima VCC, Fanelli MF, Colombo PE, da Costa AABA, Alix-Panabières C, Chinen LTD. Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma. Int J Mol Sci 2022;23. [PMID: 36499015 DOI: 10.3390/ijms232314687] [Reference Citation Analysis]
4 Kozik AV, Kaigorodova EV, Grishchenko MY, Vtorushin SV, Chernyshova AL. EPCAM+CD45+ cells in ascitic fluid of patients with ovarian cancer: a relationship with tumor marker levels and tumor grade. Sib onkol ž 2022;21:44-51. [DOI: 10.21294/1814-4861-2022-21-5-44-51] [Reference Citation Analysis]